Preferred Name |
Sufentanil Citrate |
|
Synonyms |
|
|
Definitions |
The citrate salt form of sufentanil, a synthetic congener of fentanyl and related to the phenylpieridines, with analgesic property. Sufentanil citrate binds to and activates the mu-opioid receptor, thereby producing analgesia, respiratory depression, miosis, reduced gastrointestinal motility, and euphoria. In addition, this agent has a more rapid onset of action and shorter duration of action compared to fentanyl. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C47731 |
|
CAS_Registry |
60561-17-3 |
|
Chemical_Formula |
C22H30N2O2S.C6H8O7 |
|
code |
C47731 |
|
Contributing_Source |
FDA |
|
definition |
The citrate salt form of sufentanil, a synthetic congener of fentanyl and related to the phenylpieridines, with analgesic property. Sufentanil citrate binds to and activates the mu-opioid receptor, thereby producing analgesia, respiratory depression, miosis, reduced gastrointestinal motility, and euphoria. In addition, this agent has a more rapid onset of action and shorter duration of action compared to fentanyl. |
|
FDA_UNII_Code |
S9ZFX8403R |
|
Has_Free_Acid_Or_Base_Form | ||
in_subset | ||
label |
Sufentanil Citrate |
|
Legacy Concept Name |
Sufentanil_Citrate |
|
NCI_Drug_Dictionary_ID |
524060 |
|
PDQ_Closed_Trial_Search_ID |
524060 |
|
PDQ_Open_Trial_Search_ID |
524060 |
|
Preferred_Name |
Sufentanil Citrate |
|
prefixIRI |
NCIT:C47731 |
|
prefLabel |
Sufentanil Citrate |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0162792 |
|
subClassOf |